Latest Revenue Growth News

FINEOS Corporation Holdings PLC reports solid Q3 2025 results, highlighting revenue growth, operational efficiencies, and a key North American client migration to its SaaS platform, underpinning positive free cash flow expectations for FY25.

Memphasys secures a follow-up order for its Felix™ sperm selection cartridges from a leading Japanese fertility clinic, marking growing adoption in one of the world’s largest IVF markets and signaling a strategic shift to direct sales.

Corporate Travel Management reports a 6% revenue increase and a 29% rise in EBITDA for 1QFY26, maintaining operational strength amid an ongoing audit review and trading suspension.

Vitasora Health is set to scale its AI-powered chronic care services from Hawaii to 10-15 US states, leveraging a new partnership with Privia Health following Evolent Care Partners' divestiture. This expansion targets up to 30,000 patients and promises significant revenue growth in 2026.

Pilbara Minerals has delivered a robust start to FY26, boosting lithium production and revenue while cutting unit costs at its Pilgangoora operation. The company also advances key growth projects amid a volatile lithium market.

BrainChip Holdings has moved its AKD1500 neuromorphic AI chip into volume production, supported by key supply agreements and expanded distribution channels, while maintaining a stable cash position.

Experience Co Limited reported an 8% revenue increase and 17% underlying EBITDA growth in Q1 FY26, driven by strong demand in its Adventure Experiences segment, especially Reef Unlimited, despite weather challenges affecting Skydiving operations.

Stakk Limited has reported explosive growth in its SaaS revenue and client base in 2025, positioning itself as a leading embedded finance infrastructure provider. The company’s ARR surged over 300%, driven by major US fintech partnerships and a strategic pivot to a modular SaaS model.

Janison Education Group reported solid FY25 results with 9% revenue growth and the commercial launch of its AI platform Jai, positioning itself strongly in the expanding global digital assessment market.

ReNerve Limited reported a 38% increase in quarterly sales driven by the launch of its EmpliQ product range and ongoing development of advanced nerve repair technologies. The company’s cash position remains solid as it prepares for upcoming clinical trials.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Audeara Ltd has reported a remarkable 111% revenue increase in Q1 FY26, driven by strong growth in its technology division and key international partnerships in China and Japan. The company is advancing towards cashflow breakeven with improved cash management and expanding global reach.